ARGUN AKCAKANAT to Thyroid Neoplasms
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Thyroid Neoplasms.
Connection Strength
0.092
-
Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. Sci Rep. 2022 01 24; 12(1):1248.
Score: 0.092